Bhopal activists demand probe into Covaxin trials incident
January 11, 2021
Allege gross violation of laws governing clinical trials
As the country prepares to roll out two Covid-19 vaccines on a mass scale, a clutch of organisations from Bhopal have written to the Prime Minister and Health Minister on allegations of serious violations in the Phase-3 clinical trials being conducted at the People’s College of Medical Sciences & Research Centre in Bhopal to assess the safety, immunogenicity and efficacy of Covaxin.
Covaxin is the Covid-19 vaccine from Bharat Biotech being developed in collaboration with the Indian Council of Medical Research (ICMR). It was recently approved for restricted use, (along with Serum Institute of India’s vaccine), but in a clinical trial mode - a caveat that had many scientific voices raising concerns on its implications.